Perivascular Space Progression in Patients with Cerebral Amyloid Angiopathy
European Neurology · 2026
DOI: 10.1159/000550942 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Neurology, 2026. Verfasst von Qi Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China, qili_md@126.com. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Glymphatic System. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Introduction
Dilated perivascular spaces (PVS) are associated with small vessel disease in the aging population. We sought to investigate the incidence and dynamic evolution of MRI-detectable PVS progression in patients with cerebral amyloid angiopathy (CAA).
Methods
Patients with symptomatic CAA who underwent baseline and follow-up MRI scans >2 years apart were included. The severity of both basal ganglia (BG) and centrum semiovale (CSO) PVS were rated. Multivariable logistic regression was used to determine the risk factors for PVS progression.
Results
We included 90 patients with CAA (mean age 72.6 years, SD 8.0 years), of which 53 (58.9%) had intracerebral hemorrhage (ICH) at baseline. During a median follow-up of 4.8 years (IQR 3.6 - 6.6 years), PVS progression was observed in 24 patients (26.7%) at follow-up MRI. After adjusting for age, hypertension and time between baseline and follow-up MRI, cerebral microbleed (CMB) progression (OR 4.12, 95% CI 1.31 - 12.95; p=0.015) and presence of ICH at baseline (OR 8.61, 95% CI: 2.09 - 35.52; p=0.003) were independent predictors of PVS progression. In multivariable regression analysis, presence of ICH (OR 8.78, 95% CI 1.74 - 44.35; p=0.009) and hypertension (OR 5.73, 95% CI 1.25 – 26.29; p=0.025) were associated with BG-PVS progression. However, only CMB progression (OR 10.17, 95% CI 1.84 - 56.35; p=0.008) was associated with CSO-PVS progression.
Conclusion
PVS progression occurs in a subset of CAA patients reimaged after a median of 4.8 years and is associated with CMB progression. PVS progression might be a useful neuroimaging marker for visualizing CAA-related vascular changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China, qili_md@126.com.
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA, qili_md@126.com.
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Center for Imaging Sciences and Medical Physics, Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
- Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NIA NIH HHS
- NINDS NIH HHS
Zitieren
APA
Li, Q., Zanon Zotin, M. C., Warren, A. D., van Veluw, S. J., Perosa, V., Gurol, M. E., Goldstein, J. N., Viswanathan, A., & Greenberg, S. M. (2026). Perivascular Space Progression in Patients with Cerebral Amyloid Angiopathy. European Neurology. https://doi.org/10.1159/000550942
Vancouver
Li Q, Zanon Zotin MC, Warren AD, van Veluw SJ, Perosa V, Gurol ME, et al. Perivascular Space Progression in Patients with Cerebral Amyloid Angiopathy. European Neurology. 2026. doi:10.1159/000550942
BibTeX
@article{Li2026,
author = {Li, Qi and Zanon Zotin, Maria Clara and Warren, Andrew D and van Veluw, Susanne J and Perosa, Valentina and Gurol, M Edip and Goldstein, Joshua N and Viswanathan, Anand and Greenberg, Steven M},
title = {Perivascular Space Progression in Patients with Cerebral Amyloid Angiopathy},
journal = {European Neurology},
year = {2026},
doi = {10.1159/000550942}
}
EUVIMED